Lachman Consultants Blog FDA's Interest in Increased Access to OTC Drugs-You Can Now Provide Feedback

The FDA has made clear that it is interested in hearing your thoughts on the OTC drugs approved through the NDA process and wants your feedback on a number of topics. In a pre-publication notice in the Federal Register yesterday (here), the FDA noted that it would like interested parties to "share their perspectives with [...]The post FDA's Interest in Increased Access to OTC Drugs-You Can Now Provide Feedback appeared first on Lachman Consultant Services, Inc..